Provided by Tiger Trade Technology Pte. Ltd.

Information

3.82
+0.01500.39%
Post-market: 3.820.0022+0.06%18:03 EDT
Volume:414.33K
Turnover:1.58M
Market Cap:182.92M
PE:20.08
High:3.84
Open:3.82
Low:3.75
Close:3.81
52wk High:6.45
52wk Low:3.42
Shares:47.88M
Float Shares:34.23M
Volume Ratio:1.47
T/O Rate:1.21%
Dividend:0.18
Dividend Rate:4.71%
EPS(TTM):0.1903
EPS(LYR):0.1900
ROE:9.78%
ROA:5.35%
PB:1.93
PE(LYR):20.11

Loading ...

Integral forecasts earnings boost from additional carried interest on Fund III

TIPRANKS
·
Mar 11

Press Release: Markel appoints Phil Jones as Chief Information Officer, International

Dow Jones
·
Mar 11

Enbridge Issues 2026 Management Information Circular to Shareholders

TIPRANKS
·
Mar 11

Mill City Ventures III Bets Big on SUI

TIPRANKS
·
Mar 11

Immutep Shares Suspended Pending Key Phase III Trial Futility Update

TIPRANKS
·
Mar 11

Lepu Biopharma Gains US$45 Million Milestone as AstraZeneca Advances Claudin 18.2 ADC to Phase III

TIPRANKS
·
Mar 11

Loblaw Reports Data Breach of Basic Customer Information

Dow Jones
·
Mar 11

Leonardo DRS Adds Reuben Jeffery III to Board

TIPRANKS
·
Mar 11

Barclays Publishes Information Memorandum for AUD Debt Issuance Programme

TIPRANKS
·
Mar 11

Chugai and Roche Advance NXT007 Into Phase III to Challenge Emicizumab in Hemophilia A

TIPRANKS
·
Mar 11

Hegseth Plays Down Open-Source Information in Assessing Deadly Girls' School Strike -- WSJ

Dow Jones
·
Mar 10

Cartesian III, Factorial secure strategic investments for expansion

TIPRANKS
·
Mar 10

Marc Andreessen Just Revealed His Radical Daily Information Diet— And It Doesn't Include News

Benzinga_recent_news
·
Mar 10

Archimedes Tech SPAC Partners III Co. Announces the Separate Trading of its Ordinary Shares and Warrants Commencing March 16, 2026

GlobeNewswire
·
Mar 10

Press Release: Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

Dow Jones
·
Mar 10

Vertex Pharmaceuticals: Upgraded Confidence in Povetacicept Drives Strengthened Buy Thesis After Robust Phase III RAINIER Data in IgA Nephropathy

TIPRANKS
·
Mar 10

JATAM Wins Public Information Dispute Over IKN Projects

Tempo
·
Mar 10

ABBISKO-B (02256) Surges Over 9% Again as Global Phase III MANEUVER Study Results for Beijiemai Published in The Lancet

Stock News
·
Mar 10

Altimmune Bets Big on PEMB as Phase III Nears

TIPRANKS
·
Mar 10

Clarity hits Phase III AMPLIFY enrollment goal for prostate cancer imaging agent

TIPRANKS
·
Mar 10